Gynecologic Oncology

Gynecologic Oncology

Unless otherwise specified, outcomes reported here reflect care by our gynecologic oncology staff practicing in Cleveland Clinic facilities in northeast Ohio.

The advent of robotic assisted laparoscopy has prompted an increase in minimally invasive procedures in the gynecologic subspecialties. Cleveland Clinic gynecologic oncology surgeons strive to provide the best care for patients while using minimally invasive procedures when possible.

Surgical Case Approach for Complex Benign and Malignant Cases

2017 – 2020

New Surgical Gynecologic Cancer Case Distribution

2017 - 2020

Minimal Invasive Surgery for Endometrial Cancer

2017 - 2020

Optimally Debulked Primary and Secondary Cytoreduction for Ovarian Cancer

2017 – 2020

N1 is the total of primary cytoreduction cases

N2 is the total of secondary cytoreduction cases

HIPEC Cases for Ovarian Cancer

2017 - 2020

Hyperthermic Intra peritoneal chemotherapy (HIPEC) is a technique whereby chemotherapy is administered into the abdominal cavity at the time of surgery to remove ovarian cancer. The addition of HIPEC therapy to select women with ovarian cancer has been shown to improve both progression free and overall survival from their disease. The Cleveland Clinic has one of the largest HIPEC programs for women with ovarian cancer in the country and is one of only a few programs that has a translation research program dedicated to investigating this promising new technique in Gynecologic malignancies.

Outpatient Survery vs Inpatient Surgery vs 30 days Surgical readmission

2018 – 2020

Length of Stay Following Inpatient Gynecologic Oncology Surgeryᵃ

2018 – 2020

ᵃThese data are prepared using the Vizient Clinical Database. Data from the Vizient Clinical Data Base/Resource Manager™ used by permission of Vizient. All rights reserved.

ᵇTotal number of surgical cases for gynecologic malignancy identified by MS-DRGs 734, 735, 736, 737, 738, 739, 740, 741, 754, 755, and 756.

Observed to Expected Thirty-Day Mortality Rate Following Inpatient Gynecologic Oncology Surgeryᵃ

2018 – 2020

ᵃThese data are prepared using the Vizient Clinical Database. Data from the Vizient Clinical Data Base/Resource Manager™ used by permission of Vizient. All rights reserved.

ᵇTotal number of surgical cases for gynecologic malignancy identified by MS-DRGs 734, 735, 736, 737, 738, 739, 740, 741, 754, 755, and 756.

Number of Clinical Trials Open

2018-2020

N is the total number of treatment trials.

There were a total of 109 patients enrolled in 38 gynecologic oncology treatment trials from 2017 through 2020.

Use of Brachytherapy in Patients Treated With Primary Radiation With Curative Intent in any Stage of Cervical Cancerᵃ (N = 238)

2010-2020

ᵃIncludes patients treated at main campus, Cleveland Clinic Family Health Centers, Fairview Hospital and Hillcrest Hospital.

Cleveland Clinic's performance was 91.2% (217 of 238 patients) from 2010-2020 for the use of brachytherapy in patients treated with primary radiation with curative intent in any stage of cervical cancer.

Chemotherapy Administered to Cervical Cancer Patients who Received Radiation for Stages IB2-IV Cancer or With Positive Pelvic Nodes, Positive Surgical Margin, and/or Positive Parametriumᵃ (N = 262)

2010-2020

ᵃIncludes patients treated at main campus, Cleveland Clinic Family Health Centers, Fairview Hospital and Hillcrest Hospital.

Cleveland Clinic's performance was 92.7% (243 of 262 patients) from 2010-2020 for chemotherapy administered to cervical cancer patients who received radiation for stages IB2-IV cancer or with positive pelvic nodes, positive surgical margin, and/or positive parametrium.

Radiation Therapy Completed Within 60 Days of Initiation of Radiation Among Women Diagnosed With any Stage of Cervical Cancerᵃ (N = 208)

2010-2020

ᵃIncludes patients treated at main campus, Cleveland Clinic Family Health Centers, Fairview Hospital and Hillcrest Hospital.

Cleveland Clinic's performance was 90.9% (189 of 208) patients; 95% CI, 86.1%-94.4%) from 2010-2020 for radiation therapy completed within 60 days of initiation of radiation among women diagnosed with any stage of cervical cancer.

Chemotherapy and/or Radiation Administered to Patients With Stage IIIC or IV Endometrial Cancerᵃ (N = 177)

2010-2020

ᵃIncludes patients treated at main campus, Cleveland Clinic Family Health Centers, Fairview Hospital and Hillcrest Hospital.

Cleveland Clinic's performance was 92.1% (163 of 177 patients) from 2010-2020 for chemotherapy and/or radiation administered to patients with stage IIIC or IV endometrial cancer.

Laparoscopic or Robotic Surgery Performed for all Endometrial Cancer for all Stages Except Stage IVᵃ⁻ᵇ (N = 2338)

2010-2020

ᵃIncludes patients treated at main campus, Cleveland Clinic Family Health Centers, Fairview Hospital and Hillcrest Hospital.

ᵇExcludes sarcoma and lymphoma

Cleveland Clinic's performance was 76.6% (1792 of 2338 patients; 95% CI) from 2010-2020 for laparoscopic or robotic surgery performed for endometrial cancer stages I-IIIC.